IE46047L - 21-halogenopregnanes - Google Patents

21-halogenopregnanes

Info

Publication number
IE46047L
IE46047L IE771979A IE197977A IE46047L IE 46047 L IE46047 L IE 46047L IE 771979 A IE771979 A IE 771979A IE 197977 A IE197977 A IE 197977A IE 46047 L IE46047 L IE 46047L
Authority
IE
Ireland
Prior art keywords
alpha
chlorine
gb1563638a
methylpregna
dihalo
Prior art date
Application number
IE771979A
Other versions
IE46047B1 (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE46047L publication Critical patent/IE46047L/en
Publication of IE46047B1 publication Critical patent/IE46047B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J21/00Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

9 alpha ,21-Dihalo-11 beta ,17 alpha -dihydroxy-6 alpha -fluoro-16 alpha -methylpregna-1,4-diene -3,20-dione 17-esters of the formula <IMAGE> in which X1 is chlorine or fluorine, X2 is bromine or chlorine, and Ac is an acyl group derived from a carboxylic acid, are distinguished by high local antiinflammatory activity with a reduced systemic effect, for which reason they can be used in medicine to alleviate and control inflammatory states. They are obtained by conventional replacement of an organic 21-sulphonyloxy group by halogen X2. [GB1563638A]
IE1979/77A 1976-09-29 1977-09-28 Polyhalogenated steroids IE46047B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU75903A LU75903A1 (en) 1976-09-29 1976-09-29

Publications (2)

Publication Number Publication Date
IE46047L true IE46047L (en) 1978-03-29
IE46047B1 IE46047B1 (en) 1983-02-09

Family

ID=19728370

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1979/77A IE46047B1 (en) 1976-09-29 1977-09-28 Polyhalogenated steroids

Country Status (24)

Country Link
JP (1) JPS5356652A (en)
AT (3) AT363197B (en)
AU (1) AU514200B2 (en)
BE (1) BE859120A (en)
CA (1) CA1101410A (en)
CH (9) CH624967A5 (en)
CY (1) CY1178A (en)
DD (1) DD133150A5 (en)
DE (1) DE2743069A1 (en)
DK (1) DK146017C (en)
ES (1) ES462763A1 (en)
FR (1) FR2366311A1 (en)
GB (1) GB1563638A (en)
HK (1) HK16683A (en)
HU (1) HU175218B (en)
IE (1) IE46047B1 (en)
IL (1) IL53012A (en)
KE (1) KE3258A (en)
LU (1) LU75903A1 (en)
MY (1) MY8400092A (en)
NL (1) NL7710089A (en)
SE (1) SE436751B (en)
SG (1) SG3383G (en)
ZA (1) ZA775800B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL187577C (en) * 1978-04-05 1991-11-18 Sibla Srl 3-ACETOXY-9BETA, 11BETA-EPOXY-PREGNA-1,3,5-TRIEN, PROCESS FOR THE PREPARATION THEREOF, AND PROCESS FOR THE PREPARATION OF 6-alpha-halogen-1,4-diene-3-ones.
DE3227312A1 (en) * 1982-07-19 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen NEW 6.16 DIMETHYL CORTICOIDS, THEIR PRODUCTION AND USE
WO1991014700A2 (en) * 1990-03-27 1991-10-03 Schering Corporation PROCESS FOR 9α-HYDROXY STEROID DEHYDRATION
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
CN1596241A (en) 2001-11-29 2005-03-16 塔罗制药美国公司 Method for the preparation of 6alpha-fluoro corticosteroids
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
ES2812451T3 (en) 2015-06-18 2021-03-17 Bausch Health Ireland Ltd Topical compositions comprising a corticosteroid and a retinoid to treat psoriasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB898292A (en) * 1959-03-18 1962-06-06 Upjohn Co Improvements in or relating to steroids and the manufacture thereof
US3644340A (en) * 1970-03-19 1972-02-22 Syntex Corp Preparation of 21-chloro steroids
US3992422A (en) * 1975-08-14 1976-11-16 Schering Corporation Process for the preparation of 21-halogeno-21-desoxy-17α-acyloxy-20-keto-pregnenes

Also Published As

Publication number Publication date
CH632279A5 (en) 1982-09-30
CH625808A5 (en) 1981-10-15
ATA151279A (en) 1980-12-15
AT363202B (en) 1981-07-27
DE2743069A1 (en) 1978-03-30
DK146017C (en) 1983-10-24
ES462763A1 (en) 1978-05-16
ZA775800B (en) 1978-08-30
LU75903A1 (en) 1978-05-16
IL53012A (en) 1982-05-31
ATA151379A (en) 1980-12-15
HK16683A (en) 1983-05-27
AU2914877A (en) 1979-04-05
IL53012A0 (en) 1977-11-30
IE46047B1 (en) 1983-02-09
CH624967A5 (en) 1981-08-31
DK146017B (en) 1983-05-24
CH625810A5 (en) 1981-10-15
CH632000A5 (en) 1982-09-15
CH632521A5 (en) 1982-10-15
DE2743069C2 (en) 1987-03-05
CH631998A5 (en) 1982-09-15
AT363203B (en) 1981-07-27
SG3383G (en) 1983-09-09
SE7706673L (en) 1978-03-30
CA1101410A (en) 1981-05-19
KE3258A (en) 1983-03-04
SE436751B (en) 1985-01-21
CH631999A5 (en) 1982-09-15
MY8400092A (en) 1984-12-31
HU175218B (en) 1980-06-28
FR2366311A1 (en) 1978-04-28
CY1178A (en) 1983-06-10
JPS5356652A (en) 1978-05-23
BE859120A (en) 1978-03-28
FR2366311B1 (en) 1982-12-03
GB1563638A (en) 1980-03-26
AT363197B (en) 1981-07-10
DD133150A5 (en) 1978-12-13
DK256977A (en) 1978-03-30
JPS6214557B2 (en) 1987-04-02
CH625809A5 (en) 1981-10-15
NL7710089A (en) 1978-03-31
ATA691077A (en) 1980-12-15
AU514200B2 (en) 1981-01-29

Similar Documents

Publication Publication Date Title
IE46047L (en) 21-halogenopregnanes
NO160212C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF NEW CARBOXYLIC ACID ESTERS WITH ANTI-INFLAMMATORY EFFECTS.
JPS57182221A (en) Dc power supply
SE423903B (en) PROCEDURE FOR PREPARING 9 ALFA, 21-DIHALOGEN-11 BETA, 17 ALFA-DIHYDROXY-6 ALFA-FLOUR-16 ALFA-METHYL-PREGNA-1,4-DIENE-3,20-DIONE ESTARS
JPS5686119A (en) Steroid anti-inflammatory
GB1391443A (en) Ester of betamethasone and its 9alpha-chloro analogue
IE790134L (en) 11,17ó- disubstituted pregnene-3,20-diones
GB1050900A (en)
GB1077393A (en) New steroids
GB843214A (en) Improvements in or relating to steroid compounds
GB898291A (en) Improvements in or relating to steroids and the manufacture thereof
ES461263A1 (en) 21,21-Dihalo steroids
GB1180176A (en) Novel Steroid 21-Esters, their Preparation, and Compositions containing them
GB926472A (en) New halogen-pregnenes and a process for their manufacture
ES395740A1 (en) Novel 6alpha,16alpha-dimethyl steroids
GB806045A (en) Steroids
GB959793A (en) Improvements in or relating to steroids
IE42283L (en) 6-fluoro-16-methyl-pregna-1,4,8-triene-3,20-diones
JPS5270082A (en) Microbial oxidation of steroids
JPS5233027A (en) Transistor chopper
GB921533A (en) Cyclopentanophenanthrene derivatives and process for the production thereof
ES8206468A1 (en) Process for the preparation of derivatives of 2-pyrrole acetic acid with anti-inflammatory activity
GB889311A (en) Androstenol derivatives
GB923125A (en) Steroid compounds
GB991475A (en) Novel steroid compounds and processes for their production

Legal Events

Date Code Title Description
MK9A Patent expired